glp 1 agonist guidelines Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - How should we approach patients
Description
Aids sustainable weight management
Patients have found compounded semaglutide to be a cheaper, accessible GLP-1, but health experts warn of risks tied to the non-FDA-approved drugs.
Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns
However, heterogeneous experimental designs and limited translational data necessitate further standardized and in vivo research to define clinical applications.
Compliance-first.
